Michèle Février

1.2k total citations
32 papers, 965 citations indexed

About

Michèle Février is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Michèle Février has authored 32 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 17 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Michèle Février's work include Immune Cell Function and Interaction (18 papers), HIV Research and Treatment (17 papers) and T-cell and B-cell Immunology (7 papers). Michèle Février is often cited by papers focused on Immune Cell Function and Interaction (18 papers), HIV Research and Treatment (17 papers) and T-cell and B-cell Immunology (7 papers). Michèle Février collaborates with scholars based in France, United Kingdom and Belgium. Michèle Février's co-authors include Yves Rivière, Sylvie Garcia, Angelita Rebollo, Karim Dorgham, Hervé Lecœur, Marie‐Lise Gougeon, Frédéric Tangy, P Liacopoulos, Arnaud Moris and Chantal Combredet and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michèle Février

31 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michèle Février France	16	570	354	272	246	185	32	965
Jay A. Berzofsky United States	9	702 1.2×	346 1.0×	295 1.1×	232 0.9×	295 1.6×	11	1.2k
Thomas D. Martin United States	16	564 1.0×	430 1.2×	211 0.8×	279 1.1×	261 1.4×	21	1.1k
Sylvie Lagaye France	14	407 0.7×	260 0.7×	282 1.0×	195 0.8×	137 0.7×	35	958
Sunil Kannanganat United States	14	764 1.3×	373 1.1×	318 1.2×	257 1.0×	144 0.8×	21	1.1k
Jean‐Hervé Colle France	17	502 0.9×	283 0.8×	227 0.8×	113 0.5×	144 0.8×	45	864
Bo Hejdeman Sweden	20	573 1.0×	558 1.6×	287 1.1×	325 1.3×	207 1.1×	49	1.1k
Růžena Stránská Netherlands	15	335 0.6×	379 1.1×	466 1.7×	236 1.0×	154 0.8×	17	907
Erika Schlaepfer Switzerland	19	701 1.2×	593 1.7×	208 0.8×	236 1.0×	179 1.0×	33	1.1k
Kara S. Cox United States	18	365 0.6×	276 0.8×	434 1.6×	377 1.5×	248 1.3×	30	1.0k
Diane G. Carnathan United States	18	423 0.7×	379 1.1×	210 0.8×	237 1.0×	177 1.0×	33	817

Countries citing papers authored by Michèle Février

Since Specialization

Citations

This map shows the geographic impact of Michèle Février's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Février with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Février more than expected).

Fields of papers citing papers by Michèle Février

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Février. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Février. The network helps show where Michèle Février may publish in the future.

Co-authorship network of co-authors of Michèle Février

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Février. A scholar is included among the top collaborators of Michèle Février based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Février. Michèle Février is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Escriou, Nicolas, Benoît Callendret, Valérie Lorin, et al.. (2014). Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology. 452-453. 32–41. 47 indexed citations

Stebbings, Richard, Bo Li, Clarisse Lorin, et al.. (2013). Immunogenicity of a recombinant measles HIV-1 subtype C vaccine. Vaccine. 31(51). 6079–6086. 17 indexed citations

Guerbois, Mathilde, Arnaud Moris, Chantal Combredet, et al.. (2009). Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic. Virology. 388(1). 191–203. 39 indexed citations

Brandler, Samantha, Marianne Lucas‐Hourani, Arnaud Moris, et al.. (2007). Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus. PLoS neglected tropical diseases. 1(3). e96–e96. 71 indexed citations

Cardinaud, Sylvain, Arnaud Moris, Michèle Février, et al.. (2004). Identification of Cryptic MHC I–restricted Epitopes Encoded by HIV-1 Alternative Reading Frames. The Journal of Experimental Medicine. 199(8). 1053–1063. 65 indexed citations

Février, Michèle, Sylvie Le Borgne, Christian Marty, Antoine Talarmin, & Yves Rivière. (2004). Functional Characterization of Human Tc0, Tc1 and Tc2 CD8⁺T Cell Clones: Control of X4 and R5 HIV Strain Replication. Journal of Clinical Immunology. 24(3). 272–280. 4 indexed citations

Monceaux, Valérie, Jérôme Estaquier, Michèle Février, et al.. (2003). Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS. AIDS. 17(11). 1585–1596. 52 indexed citations

Lecœur, Hervé, Michèle Février, Sylvie Garcia, Yves Rivière, & Marie‐Lise Gougeon. (2001). A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. Journal of Immunological Methods. 253(1-2). 177–187. 184 indexed citations

Borgne, Sylvie Le, Michèle Février, Christian Callebaut, Steven P. Lee, & Yves Rivière. (2000). CD8⁺-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription. Journal of Virology. 74(10). 4456–4464. 35 indexed citations

10.

Février, Michèle, et al.. (1997). Interleukin‐2 receptor β and γ chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus‐1 gp120. European Journal of Immunology. 27(9). 2188–2194. 7 indexed citations

11.

Buseyne, Florence, et al.. (1996). Dual Function of a Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Clone: Inhibition of HIV Replication by Noncytolytic Mechanisms and Lysis of HIV-Infected CD4+ Cells. Virology. 225(1). 248–253. 47 indexed citations

12.

Février, Michèle, et al.. (1995). Two New Human Monoclonal Antibodies against HIV Type 1 Glycoprotein 120: Characterization and Neutralizing Activities against HIV Type 1 Strains. AIDS Research and Human Retroviruses. 11(4). 491–500. 2 indexed citations

13.

Prigent, Philippe, Pascal Poncet, Jan Aten, et al.. (1995). Mercuric Chloride-Induced Programmed Cell Death of a Murine T Cell Hybridoma. Cellular Immunology. 161(1). 107–111. 9 indexed citations

14.

Février, Michèle, Florence Boudet, Jean‐Philippe Corre, et al.. (1992). Idiotypic Expression of Anti-gp120 Antibodies in Unrelated Human Immunodeficiency Virus-infected Individuals. Journal of General Virology. 73(10). 2561–2568. 3 indexed citations

15.

Corre, Jean‐Philippe, Michèle Février, Jacques Thèze, Moncef Zouali, & S. Chamaret. (1991). Anti‐idiotypic antibodies to human anti‐gp120 antibodies bind recombinant and cellular human CD4. European Journal of Immunology. 21(3). 743–751. 22 indexed citations

16.

Diu, Anita, Michèle Février, Pascale Mollier, et al.. (1990). Further evidence for a human B cell activating factor distinct from IL-4. Cellular Immunology. 125(1). 14–28. 3 indexed citations

17.

Deist, F Le, Michèle Février, Anita Diu, et al.. (1990). Human severe combined immunodeficiency disease: phenotypic and functional characteristics of peripheral B lymphocytes.. The Journal of Immunology. 145(9). 2873–2879. 33 indexed citations

18.

Février, Michèle, Pascale Mollier, A Abadie, et al.. (1989). Human B cell activating factor (BCAF): production by a human T cell tumor line.. PubMed. 8(1). 59–67. 2 indexed citations

19.

Couderc, J, et al.. (1987). Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.. PubMed. 61(1). 71–6. 7 indexed citations

20.

Février, Michèle. (1985). Antigen-nonspecific macrophage factors modulating the antibody response in vitro. Comparative Immunology Microbiology and Infectious Diseases. 8(2). 159–170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact